510(k) · Cardiovascular

AusculThing ACC

by AusculThing Oy

AusculThing ACC is an AI-enabled medical device from AusculThing Oy that the U.S. FDA cleared through 510(k) K230823 on July 12, 2023. Its lead review panel is Cardiovascular and its primary product code is DQD (Stethoscope, Electronic).

See also FDA-cleared AI cardiovascular devices in 2023, all FDA AI clearances in 2023, top cardiovascular AI devices.

Key facts

Submission numberK230823
Pathway510(k)
Date of final decision
Company (FDA list)AusculThing Oy
Lead review panelCardiovascular
Primary product codeDQD — Stethoscope, Electronic
Applicant (openFDA)Ausculthing OY
Applicant locationEspoo, FI
Device classClass 2
Regulation number21 CFR 870.1875
Decision codeSESE
Submission typeTraditional

Source: FDA AI-Enabled Medical Devices list and openFDA.

What this means

A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. AusculThing ACC went through this pathway (K230823).

openFDA lists it as a Class 2 device under 21 CFR 870.1875. Class II devices are moderate risk and are subject to general and special controls.

Product code DQD covers 14 devices on the FDA AI list. By decision date, this device is #9 of 14 under that code. AusculThing Oy has 1 AI-enabled device on the list, and the Cardiovascular panel accounts for 154 in total.

Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.

Similar devices (product code DQD)